NIP
Nicholas Investment Partners’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-414,419
| Closed | -$37.8M | – | 186 |
|
|
2023
Q2 | $37.8M | Buy |
414,419
+77,468
| +23% | +$7.06M | 2.58% | 3 |
|
|
2023
Q1 | $22.2M | Buy |
336,951
+88,668
| +36% | +$5.85M | 1.69% | 18 |
|
|
2022
Q4 | $12.8M | Buy |
248,283
+53,770
| +28% | +$2.78M | 1.12% | 35 |
|
|
2022
Q3 | $13.3M | Buy |
194,513
+69,018
| +55% | +$4.71M | 1.23% | 26 |
|
|
2022
Q2 | $5.68M | Buy |
125,495
+63,495
| +102% | +$2.87M | 0.54% | 69 |
|
|
2022
Q1 | $3.15M | Buy |
+62,000
| New | +$3.15M | 0.22% | 123 |
|